Inveresk (NASDAQ:IRGI)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Inveresk Charts. Click Here for more Inveresk Charts.](/p.php?pid=staticchart&s=N%5EIRGI&p=8&t=15)
Inveresk Research Announces Fourth Quarter and Full Year 2003 Earnings Release
and Webcast
Conference Call on Tuesday, February 3, 2004 at 10:00 a.m. EST
CARY, N.C., Jan. 8 /PRNewswire-FirstCall/ -- Inveresk Research Group, Inc.
will be announcing its fourth quarter and full year earnings results for the
fiscal year ended December 31, 2003, after the market closes on Monday, February
2, 2004.
Management of the company will host a conference call to discuss these results
on Tuesday, February 3, 2004, at 10:00 a.m. Eastern Standard Time. Presenting
from the company will be Walter Nimmo, President and Chief Executive Officer and
Paul Cowan, Chief Financial Officer.
The conference call will be webcast live and will also be available for replay
two hours after the completion of the call until 5:00 pm EST on Tuesday,
February 10, 2004. To access the webcast, visit the Company's web site at
http://www.inveresk.com/.
Inveresk Research is a leading provider of drug development services to
companies in the pharmaceutical and biotechnology industries. Through its
pre-clinical and clinical business segments, the Company offers a broad range of
drug development services, including pre-clinical safety and pharmacology
evaluation services, laboratory sciences services and clinical development
services. Inveresk Research is one of a small number of drug development
services companies currently providing a comprehensive range of pre-clinical and
clinical development services on a worldwide basis. The Company's client base
includes major pharmaceutical companies in North America, Europe and Japan, as
well as many biotechnology and specialty pharmaceutical companies. For more
information on Inveresk Research, visit the Company's web site at
http://www.inveresk.com/.
DATASOURCE: Inveresk Research Group, Inc.
CONTACT: Matt Dallas of Financial Dynamics, +1-212-850-5627,
, for Inveresk Research Group, Inc.
Web site: http://www.inveresk.com/